Jesse Z. Dong

发表

Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.

W. Mitch, D. Marks, Zhaoyong Hu, 2008, Endocrinology.

Pseudopeptide farnesyl-protein transferase inhibitors containing 5,5-dimethylthiazolidine-4-carboxylic acid

B. Morgan, P. Kasprzyk, G. Prévost, 2002 .

There Are Three Distinct Forms of Bombesin

B. Gibson, A. Falick, E. Spindel, 1996, The Journal of Biological Chemistry.

Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion.

S. Melmed, M. Culler, S. Ren, 2003, The Journal of clinical endocrinology and metabolism.

Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.

K. Clément, A. Basdevant, P. Plas, 2010, The Journal of endocrinology.

Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice

M. Culler, A. Butler, Hyunwon Yang, 2009, Peptides.

Ghrelin and Its Analogues, BIM-28131 and BIM-28125, Improve Body Weight and Regulate the Expression of MuRF-1 and MAFbx in a Rat Heart Failure Model

S. Anker, M. Culler, R. Datta, 2011, PloS one.

Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model.

S. Anker, M. Culler, R. Datta, 2013, International journal of cardiology.

Taspoglutide, an analog of human glucagon-like Peptide-1 with enhanced stability and in vivo potency.

M. Culler, M. Cawthorne, John E. Taylor, 2010, Endocrinology.

Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques

D. Marks, M. Culler, M. Cowley, 2013, Diabetes.

Novel analogs of ghrelin: physiological and clinical implications.

T. Horvath, M. Culler, S. Diano, 2004, European journal of endocrinology.

Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study.

M. Culler, G. Stalla, M. Theodoropoulou, 2008, Endocrine-related cancer.

Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.

D. Marks, A. Inui, M. Culler, 2007, Endocrinology.

A Novel Growth Hormone Secretagogue-1a Receptor Antagonist That Blocks Ghrelin-Induced Growth Hormone Secretion but Induces Increased Body Weight Gain

T. Horvath, M. Culler, S. Diano, 2005, Neuroendocrinology.

A GHS-1a Receptor Agonist that is Highly Effective in Stimulating Body Weight Gain

M. Culler, R. Datta, H. Halem, 2006 .

Chimeric Somatostatin–Dopamine Compounds (Dopastatins) for the Treatment of Neuroendocrine Disease

M. Culler, N. Tsomaia, J. Dong, 2017 .

Synthesis of human GLP-1 (7–36) by chemoselective α-ketoacid–hydroxylamine peptide ligation of unprotected fragments

J. Bode, Javier Ruíz-Rodríguez, J. Comstock, 2011 .

Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats.

L. Burget, S. Anker, P. Pfluger, 2008, American journal of physiology. Endocrinology and metabolism.

Targeted Delivery to Cartilage Is Critical for In Vivo Efficacy of Insulin‐like Growth Factor 1 in a Rat Model of Osteoarthritis

Richard T. Lee, P. Patwari, F. Loffredo, 2014, Arthritis & rheumatology.

Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.

J. Taylor, M. Culler, H. Dufour, 2005, European journal of endocrinology.

Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

S. Melmed, I. Shimon, J. Taylor, 1997, The Journal of clinical investigation.

Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131.

M. Culler, L. V. D. van der Ploeg, R. Datta, 2014, Life sciences.

Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model

Volker Adams, G. Schuler, S. Anker, 2012, Journal of cachexia, sarcopenia and muscle.

Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.

Ricardo Lage, David Carling, Antonio Vidal-Puig, 2008, Cell metabolism.

BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.

J. Taylor, M. Culler, A. Barlier, 2005, Journal of endocrinological investigation.

Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.

R. Kesterson, J. Stephens, M. Culler, 2008, Cell metabolism.

PYY3‐36 as an anti‐obesity drug target

D. Allison, R. Seeley, M. Tschöp, 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125

D. Cocchi, M. Culler, R. Datta, 2007, Pituitary.

No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure.

S. Anker, M. Culler, R. Datta, 2009, International journal of cardiology.

Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats.

L. Burget, S. Anker, P. Pfluger, 2008, American Journal of Physiology. Endocrinology and Metabolism.

Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability.

T. Horvath, P. Pfluger, M. Tschöp, 2008, Endocrinology.

There Are Three Distinct Forms of Bombesin IDENTIFICATION OF [Leu 13 ]BOMBESIN, [Phe 13 ]BOMBESIN, AND [Ser 3 ,Arg 10 ,Phe 13 ]BOMBESIN IN THE FROG BOMBINA ORIENTALIS *

B. Gibson, A. Falick, E. Spindel, 1996 .

Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.

S. Melmed, M. Culler, S. Ren, 2007, Endocrinology.

Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells.

I. Shimon, H. Rubinfeld, J. Taylor, 2004, European journal of endocrinology.

Discovery and characterization of taspoglutide, a novel analogue of human glucagon‐like peptide‐1, engineered for sustained therapeutic activity in type 2 diabetes

N. Tsomaia, D. Mierke, Jundong Zhang, 2011, Diabetes, obesity & metabolism.